vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and OLYMPIC STEEL INC (ZEUS). Click either name above to swap in a different company.

CLOVER HEALTH INVESTMENTS, CORP. is the larger business by last-quarter revenue ($749.2M vs $490.7M, roughly 1.5× OLYMPIC STEEL INC). CLOVER HEALTH INVESTMENTS, CORP. runs the higher net margin — 3.6% vs 0.4%, a 3.2% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (62.0% vs 4.4%). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (45.0% CAGR vs 0.1%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Olympic Steel, Inc. is a metals service center based in Cleveland, Ohio. The company processes and distributes carbon, coated and stainless flat-rolled sheet, coil and plate steel, aluminium alloy, tin plate, and metal-intensive branded products primarily in the United States. Metals processing and value added services include tempering, stretch leveling, cutting-to-length, slitting, edging, shearing, blanking, burning, forming, shot blasting, laser punching, plate rolling, fabricating, machi...

CLOV vs ZEUS — Head-to-Head

Bigger by revenue
CLOV
CLOV
1.5× larger
CLOV
$749.2M
$490.7M
ZEUS
Growing faster (revenue YoY)
CLOV
CLOV
+57.7% gap
CLOV
62.0%
4.4%
ZEUS
Higher net margin
CLOV
CLOV
3.2% more per $
CLOV
3.6%
0.4%
ZEUS
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
45.0%
0.1%
ZEUS

Income Statement — Q1 FY2026 vs Q3 FY2025

Metric
CLOV
CLOV
ZEUS
ZEUS
Revenue
$749.2M
$490.7M
Net Profit
$27.3M
$2.2M
Gross Margin
Operating Margin
3.6%
1.5%
Net Margin
3.6%
0.4%
Revenue YoY
62.0%
4.4%
Net Profit YoY
-21.2%
EPS (diluted)
$0.05
$0.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
ZEUS
ZEUS
Q1 26
$749.2M
Q4 25
$487.7M
Q3 25
$496.6M
$490.7M
Q2 25
$477.6M
$496.5M
Q1 25
$462.3M
$492.9M
Q4 24
$337.0M
$418.8M
Q3 24
$331.0M
$470.0M
Q2 24
$356.3M
$526.3M
Net Profit
CLOV
CLOV
ZEUS
ZEUS
Q1 26
$27.3M
Q4 25
$-49.3M
Q3 25
$-24.4M
$2.2M
Q2 25
$-10.6M
$5.2M
Q1 25
$-1.3M
$2.5M
Q4 24
$-22.1M
$3.9M
Q3 24
$-9.2M
$2.7M
Q2 24
$7.4M
$7.7M
Gross Margin
CLOV
CLOV
ZEUS
ZEUS
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
24.5%
Q2 24
30.3%
Operating Margin
CLOV
CLOV
ZEUS
ZEUS
Q1 26
3.6%
Q4 25
-10.1%
Q3 25
-4.9%
1.5%
Q2 25
-2.2%
2.3%
Q1 25
-0.3%
1.6%
Q4 24
-6.4%
2.1%
Q3 24
-2.7%
1.7%
Q2 24
2.0%
2.9%
Net Margin
CLOV
CLOV
ZEUS
ZEUS
Q1 26
3.6%
Q4 25
-10.1%
Q3 25
-4.9%
0.4%
Q2 25
-2.2%
1.1%
Q1 25
-0.3%
0.5%
Q4 24
-6.6%
0.9%
Q3 24
-2.8%
0.6%
Q2 24
2.1%
1.5%
EPS (diluted)
CLOV
CLOV
ZEUS
ZEUS
Q1 26
$0.05
Q4 25
Q3 25
$0.18
Q2 25
$0.45
Q1 25
$0.21
Q4 24
$0.33
Q3 24
$0.23
Q2 24
$0.66

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
ZEUS
ZEUS
Cash + ST InvestmentsLiquidity on hand
$177.6M
$7.5M
Total DebtLower is stronger
$240.9M
Stockholders' EquityBook value
$339.4M
$579.1M
Total Assets
$697.7M
$1.1B
Debt / EquityLower = less leverage
0.42×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
ZEUS
ZEUS
Q1 26
$177.6M
Q4 25
$78.3M
Q3 25
$7.5M
Q2 25
$14.8M
Q1 25
$13.3M
Q4 24
$194.5M
$11.9M
Q3 24
$288.0M
$11.1M
Q2 24
$254.8M
$9.4M
Total Debt
CLOV
CLOV
ZEUS
ZEUS
Q1 26
Q4 25
Q3 25
$240.9M
Q2 25
$233.2M
Q1 25
$235.4M
Q4 24
$272.5M
Q3 24
$197.3M
Q2 24
$209.2M
Stockholders' Equity
CLOV
CLOV
ZEUS
ZEUS
Q1 26
$339.4M
Q4 25
$308.7M
Q3 25
$340.9M
$579.1M
Q2 25
$344.2M
$578.2M
Q1 25
$336.1M
$574.2M
Q4 24
$341.1M
$573.9M
Q3 24
$342.2M
$570.6M
Q2 24
$324.9M
$569.5M
Total Assets
CLOV
CLOV
ZEUS
ZEUS
Q1 26
$697.7M
Q4 25
$541.0M
Q3 25
$559.7M
$1.1B
Q2 25
$575.0M
$1.1B
Q1 25
$583.7M
$1.1B
Q4 24
$580.7M
$1.0B
Q3 24
$653.0M
$1.0B
Q2 24
$674.2M
$1.0B
Debt / Equity
CLOV
CLOV
ZEUS
ZEUS
Q1 26
Q4 25
Q3 25
0.42×
Q2 25
0.40×
Q1 25
0.41×
Q4 24
0.47×
Q3 24
0.35×
Q2 24
0.37×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
ZEUS
ZEUS
Operating Cash FlowLast quarter
$-5.4M
Free Cash FlowOCF − Capex
$-12.9M
FCF MarginFCF / Revenue
-2.6%
Capex IntensityCapex / Revenue
1.5%
Cash ConversionOCF / Net Profit
-2.50×
TTM Free Cash FlowTrailing 4 quarters
$41.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
ZEUS
ZEUS
Q1 26
Q4 25
$-66.9M
Q3 25
$12.1M
$-5.4M
Q2 25
$5.4M
$15.5M
Q1 25
$-16.3M
$49.4M
Q4 24
$34.8M
$14.6M
Q3 24
$50.0M
$24.6M
Q2 24
$44.8M
$-2.9M
Free Cash Flow
CLOV
CLOV
ZEUS
ZEUS
Q1 26
Q4 25
$-69.0M
Q3 25
$11.4M
$-12.9M
Q2 25
$4.8M
$6.8M
Q1 25
$-16.5M
$40.6M
Q4 24
$33.3M
$7.4M
Q3 24
$49.6M
$15.6M
Q2 24
$44.4M
$-11.3M
FCF Margin
CLOV
CLOV
ZEUS
ZEUS
Q1 26
Q4 25
-14.1%
Q3 25
2.3%
-2.6%
Q2 25
1.0%
1.4%
Q1 25
-3.6%
8.2%
Q4 24
9.9%
1.8%
Q3 24
15.0%
3.3%
Q2 24
12.5%
-2.2%
Capex Intensity
CLOV
CLOV
ZEUS
ZEUS
Q1 26
Q4 25
0.4%
Q3 25
0.1%
1.5%
Q2 25
0.1%
1.7%
Q1 25
0.0%
1.8%
Q4 24
0.5%
1.7%
Q3 24
0.1%
1.9%
Q2 24
0.1%
1.6%
Cash Conversion
CLOV
CLOV
ZEUS
ZEUS
Q1 26
Q4 25
Q3 25
-2.50×
Q2 25
2.96×
Q1 25
19.70×
Q4 24
3.75×
Q3 24
9.01×
Q2 24
6.04×
-0.38×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

ZEUS
ZEUS

Carbon Flat Products$268.2M55%
Specialty Metals Flat Products$140.9M29%
Tubular And Pipe Products$81.6M17%

Related Comparisons